An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced or Metastatic Soft Tissue Sarcoma (Study E7389-J081-217)
Clinical trial NCT01458249 · COMPLETED
Trial details
- NCT number
- NCT01458249
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-11-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.